349 related articles for article (PubMed ID: 216821)
1. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency.
Dolman LI; Nolan G; Jubiz W
JAMA; 1979 Mar; 241(12):1251-3. PubMed ID: 216821
[TBL] [Abstract][Full Text] [Related]
2. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
[TBL] [Abstract][Full Text] [Related]
3. Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency.
Endert E; Ouwehand A; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2005 Dec; 63(11):435-43. PubMed ID: 16397312
[TBL] [Abstract][Full Text] [Related]
4. [Discordance between the short and standard metyrapone tests in isolated corticotropin insufficiency].
Chanson P; Rieu M; Strauch G; Laudat MH
Ann Endocrinol (Paris); 1987; 48(6):465-7. PubMed ID: 2833152
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma ACTH in the metyrapone test is insufficient for the diagnosis of secondary adrenal insufficiency.
Papierska L; Rabijewski M; Migda B; Leszczyńska D; Nowak K; Łebek-Szatańska A; Glinicki P; Zgliczyński W
Front Endocrinol (Lausanne); 2022; 13():1004129. PubMed ID: 36440206
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
Calis M; Gökçe C; Ates F; Ulker S; Izgi HB; Demir H; Kirnap M; Sofuoglu S; Durak AC; Tutus A; Kelestimur F
J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242
[TBL] [Abstract][Full Text] [Related]
7. Improved single-dose metyrapone test.
Dickstein G; Barzilai D
Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
[TBL] [Abstract][Full Text] [Related]
8. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
[TBL] [Abstract][Full Text] [Related]
9. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
Matsuki M; Nishida S; Horino M; Tenku A; Oyama H
Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
[TBL] [Abstract][Full Text] [Related]
10. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
[TBL] [Abstract][Full Text] [Related]
11. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
Blevins LS; Dobs AS; Wand GS
Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the three hour metyrapone test in adults.
Best JD; Alford FP; Donald RA
Clin Endocrinol (Oxf); 1980 Jul; 13(1):69-76. PubMed ID: 6254698
[TBL] [Abstract][Full Text] [Related]
13. Plasma ACTH in diagnosis and control of adrenal disorders.
Girard J; Eberle AN; Baumann JB
Acta Endocrinol Suppl (Copenh); 1986; 279():254-8. PubMed ID: 3022521
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
Nelson JC; Tindall DJ
Am J Med Sci; 1978; 275(2):165-72. PubMed ID: 208417
[TBL] [Abstract][Full Text] [Related]
15. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood.
Gonc EN; Kandemir N; Kinik ST
Horm Res; 2003; 60(4):191-7. PubMed ID: 14530608
[TBL] [Abstract][Full Text] [Related]
16. [Plasma 11-deoxycortisol response to single dose metyrapone in prostatic cancer patients (author's transl)].
Ohashi T; Morioka M; Akaeda T; Mitsuhata N; Takeda K; Ohmori H; Saito T; Takami T; Kanbegawa A
Nihon Naibunpi Gakkai Zasshi; 1981 Jul; 57(7):983-96. PubMed ID: 6269918
[TBL] [Abstract][Full Text] [Related]
17. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
Golier JA; Schmeidler J; Yehuda R
Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
[TBL] [Abstract][Full Text] [Related]
18. Dynamic evaluation of adrenal hypofunction.
Nieman LK
J Endocrinol Invest; 2003; 26(7 Suppl):74-82. PubMed ID: 14604069
[TBL] [Abstract][Full Text] [Related]
19. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
[TBL] [Abstract][Full Text] [Related]
20. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test.
Steiner H; Bähr V; Exner P; Oelkers PW
Exp Clin Endocrinol; 1994; 102(1):33-8. PubMed ID: 8005206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
